Pneumococcal disease manifestation in children before and after vaccination: What's new?

Vaccine

Volumn 29, Issue SUPPL. 3, 2011, Pages

  Andrade, Ana Lucia ^a   Toscano, Cristiana M ^a   Minamisava, Ruth ^a   Costa, Paulo Sucasas ^a   Andrade, João Guimarães ^a  

^a FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

Author keywords

Children; Conjugate vaccine; Latin America; Pneumococcal disease; Streptococcus pneumoniae

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; C REACTIVE PROTEIN; COTRIMOXAZOLE; IBUPROFEN; PENICILLIN G; PNEUMOCOCCUS VACCINE;

ACUTE OTITIS MEDIA; ANTIBIOTIC THERAPY; ARTICLE; ATELECTASIS; BACTERIAL PERITONITIS; BACTERIAL PNEUMONIA; BACTERIAL SINUSITIS; CHILDHOOD DISEASE; COMMUNITY ACQUIRED PNEUMONIA; DRUG TREATMENT FAILURE; EMPYEMA; HAEMOPHILUS INFLUENZAE; HEALTH CARE COST; HEMOLYTIC UREMIC SYNDROME; HUMAN; LUNG ABSCESS; NEISSERIA MENINGITIDIS; PARAPNEUMONIC PLEURAL EFFUSION; PERITONITIS; PLEURA EFFUSION; PNEUMATOCELE; PNEUMOCOCCAL INFECTION; PNEUMOCOCCAL MENINGITIS; PNEUMOCOCCAL PRIMARY PERITONITIS; PNEUMOTHORAX; PRIORITY JOURNAL; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; STREPTOCOCCUS PNEUMONIAE; THORAX RADIOGRAPHY; VACCINATION; VIRUS PNEUMONIA;

BACTEREMIA; CHILD; CHILD, PRESCHOOL; FEMALE; HEMOLYTIC-UREMIC SYNDROME; HUMANS; INFANT; LATIN AMERICA; MALE; MENINGITIS, PNEUMOCOCCAL; PERITONITIS; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; RESPIRATORY TRACT INFECTIONS; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; VACCINATION; VACCINES, CONJUGATE;

EID: 80052390746     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.06.096     Document Type: Article

References (185)

1. O'Brien K.L., Wolfson L.J., Watt J.P., Henkle E., Deloria-Knoll M., McCall N., et al. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet 2009, 374(9693):893-902.
2. Pneumococcal conjugate vaccine for childhood immunization - WHO position paper. Wkly Epidemiol Rec 2007;82(12):93-104.
3. Gray B.M., Converse G.M., Dillon H.C. Epidemiologic studies of Streptococcus pneumoniae in infants: acquisition, carriage, and infection during the first 24 months of life. J Infect Dis 1980, 142(6):923-933.
4. Granat S.M., Mia Z., Ollgren J., Herva E., Das M., Piirainen L., et al. Longitudinal study on pneumococcal carriage during the first year of life in Bangladesh. Pediatr Infect Dis J 2007, 26(4):319-324.
5. Hill P.C., Cheung Y.B., Akisanya A., Sankareh K., Lahai G., Greenwood B.M., et al. Nasopharyngeal carriage of Streptococcus pneumoniae in Gambian infants: a longitudinal study. Clin Infect Dis 2008, 46(6):807-814.
6. Darboe M.K., Fulford A.J., Secka O., Prentice A.M. The dynamics of nasopharyngeal streptococcus pneumoniae carriage among rural Gambian mother-infant pairs. BMC Infect Dis 2010, 10:195.
7. Bogaert D., De Groot R., Hermans P.W. Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect Dis 2004, 4(3):144-154.
8. Hill P.C., Townend J., Antonio M., Akisanya B., Ebruke C., Lahai G., et al. Transmission of Streptococcus pneumoniae in rural Gambian villages: a longitudinal study. Clin Infect Dis 2010, 50(11):1468-1476.
9. Dagan R., Melamed R., Muallem M., Piglansky L., Yagupsky P. Nasopharyngeal colonization in southern Israel with antibiotic-resistant pneumococci during the first 2 years of life: relation to serotypes likely to be included in pneumococcal conjugate vaccines. J Infect Dis 1996, 174(6):1352-1355.
10. De Lencastre H., Tomasz A. From ecological reservoir to disease: the nasopharynx, day-care centres and drug-resistant clones of Streptococcus pneumoniae. J Antimicrob Chemother 2002, 50(Suppl S2):75-81.
11. Klugman K.P. Clinical impact of antibiotic resistance in respiratory tract infections. Int J Antimicrob Agents 2007, 29(Suppl 1):S6-S10.
12. Greenberg D., Hoffman S., Leibovitz E., Dagan R. Acute otitis media in children: association with day care centers - antibacterial resistance, treatment, and prevention. Paediatr Drugs 2008, 10(2):75-83.
13. Franco C.M., Andrade A.L., Andrade J.G., Almeida e Silva S., Oliveira C.R., Pimenta F.C., et al. Survey of nonsusceptible nasopharyngeal Streptococcus pneumoniae isolates in children attending day-care centers in Brazil. Pediatr Infect Dis J 2010, 29(1):77-79.
14. Nelson A.L., Roche A.M., Gould J.M., Chim K., Ratner A.J., Weiser J.N. Capsule enhances pneumococcal colonization by limiting mucus-mediated clearance. Infect Immun 2007, 75(1):83-90.
15. Bentley S.D., Aanensen D.M., Mavroidi A., Saunders D., Rabbinowitsch E., Collins M., et al. Genetic analysis of the capsular biosynthetic locus from all 90 pneumococcal serotypes. PLoS Genet 2006, 2(3):e31.
16. Hausdorff W.P., Bryant J., Paradiso P.R., Siber G.R. Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I. Clin Infect Dis 2000, 30(1):100-121.
17. Gratten M., Manning K., Dixon J., Morey F., Torzillo P., Hanna J., et al. Upper airway carriage by Haemophilus influenzae and Streptococcus pneumoniae in Australian aboriginal children hospitalised with acute lower respiratory infection. Southeast Asian J Trop Med Public Health 1994, 25(1):123-131.
18. Lloyd-Evans N., O'Dempsey T.J., Baldeh I., Secka O., Demba E., Todd J.E., et al. Nasopharyngeal carriage of pneumococci in Gambian children and in their families. Pediatr Infect Dis J 1996, 15(10):866-871.
19. O'Brien K.L., Nohynek H. Report from a WHO Working Group: standard method for detecting upper respiratory carriage of Streptococcus pneumoniae. Pediatr Infect Dis J 2003, 22(2):e1-e11.
20. Bogaert D., Veenhoven R.H., Sluijter M., Sanders E.A., de Groot R., Hermans P.W. Colony blot assay: a useful method to detect multiple pneumococcal serotypes within clinical specimens. FEMS Immunol Med Microbiol 2004, 41(3):259-264.
21. Hare K.M., Morris P., Smith-Vaughan H., Leach A.J. Random colony selection versus colony morphology for detection of multiple pneumococcal serotypes in nasopharyngeal swabs. Pediatr Infect Dis J 2008, 27(2):178-180.
22. Brugger S.D., Frey P., Aebi S., Hinds J., Muhlemann K. Multiple colonization with S. pneumoniae before and after introduction of the seven-valent conjugated pneumococcal polysaccharide vaccine. PLoS One 2010, 5(7):e11638.
23. Rivera-Olivero I.A., Blommaart M., Bogaert D., Hermans P.W., de Waard J.H. Multiplex PCR reveals a high rate of nasopharyngeal pneumococcal 7-valent conjugate vaccine serotypes co-colonizing indigenous Warao children in Venezuela. J Med Microbiol 2009, 58(Pt 5):584-587.
24. de Andrade A.L., Pimenta F.C., Brandileone M.C., Laval C.A., Guerra M.L., de Andrade J.G., et al. Genetic relationship between Streptococcus pneumoniae isolates from nasopharyngeal and cerebrospinal fluid of two infants with pneumococcal meningitis. J Clin Microbiol 2003, 41(8):3970-3972.
25. Mulholland K. Global burden of acute respiratory infections in children: implications for interventions. Pediatr Pulmonol 2003, 36(6):469-474.
26. Shouval D.S., Greenberg D., Givon-Lavi N., Porat N., Dagan R. Site-specific disease potential of individual Streptococcus pneumoniae serotypes in pediatric invasive disease, acute otitis media and acute conjunctivitis. Pediatr Infect Dis J 2006, 25(7):602-607.
27. Dagan R., Leibovitz E., Greenberg D., Yagupsky P., Fliss D.M., Leiberman A. Dynamics of pneumococcal nasopharyngeal colonization during the first days of antibiotic treatment in pediatric patients. Pediatr Infect Dis J 1998, 17(10):880-885.
28. Nuorti J.P., Whitney C.G. Prevention of pneumococcal disease among infants and children - use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine - recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2010, 59(RR-11):1-18.
29. Rein M.F., Gwaltney J.M., O'Brien W.M., Jennings R.H., Mandell G.L. Accuracy of Gram's stain in identifying pneumococci in sputum. JAMA 1978, 239(25):2671-2673.
30. Popovic T, Ajello G, Facklam R. Laboratory methods for the diagnosis of meningitis caused by Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae. Geneva, Switzerland: World Health Organization. Communicable Disease Surveillance and Response; 1999.
31. Constenla D, Gomez E, de la Hoz FP, O'Loughlin R, Sinha A, Valencia JE, et al. The burden of pneumococcal disease and cost-effectiveness of a pneumococcal vaccine in Latin America and the Caribbean: a review of the evidence and a preliminary economic analysis - 2007. Report. Washington, DC: A collaborative project of: The Albert B. Sabin Vaccine Institute, Pan American Health Organization, GAVI's Pneumococcal Accelerated Development and Introduction Plan at Johns Hopkins (PneumoADIP) Centers for Disease Control and Prevention; 2007.
32. Obaro S., Adegbola R. The pneumococcus: carriage, disease and conjugate vaccines. J Med Microbiol 2002, 51(2):98-104.
33. Dowell S.F., Butler J.C., Giebink G.S., Jacobs M.R., Jernigan D., Musher D.M., et al. Acute otitis media: management and surveillance in an era of pneumococcal resistance - a report from the Drug-resistant Streptococcus pneumoniae Therapeutic Working Group. Pediatr Infect Dis J 1999, 18(1):1-9.
34. Schwartz L.E., Brown R.B. Purulent otitis media in adults. Arch Intern Med 1992, 152(11):2301-2304.
35. Rodgers G.L., Arguedas A., Cohen R., Dagan R. Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: potential implications for pneumococcal conjugate vaccines. Vaccine 2009, 27(29):3802-3810.
36. Dagan R., Givon-Lavi N., Leibovitz E., Greenberg D., Porat N. Introduction and proliferation of multidrug-resistant Streptococcus pneumoniae serotype 19A clones that cause acute otitis media in an unvaccinated population. J Infect Dis 2009, 199(6):776-785.
37. Pichichero M.E., Casey J.R. Emergence of a multiresistant serotype 19A pneumococcal strain not included in the 7-valent conjugate vaccine as an otopathogen in children. JAMA 2007, 298(15):1772-1778.
38. Kero P., Piekkala P. Factors affecting the occurrence of acute otitis media during the first year of life. Acta Paediatr Scand 1987, 76(4):618-623.
39. Paradise J.L., Rockette H.E., Colborn D.K., Bernard B.S., Smith C.G., Kurs-Lasky M., et al. Otitis media in 2253 Pittsburgh-area infants: prevalence and risk factors during the first two years of life. Pediatrics 1997, 99(3):318-333.
40. Curns A.T., Holman R.C., Shay D.K., Cheek J.E., Kaufman S.F., Singleton R.J., et al. Outpatient and hospital visits associated with otitis media among American Indian and Alaska native children younger than 5 years. Pediatrics 2002, 109(3). E41-1.
41. Casselbrant M.L., Mandel E.M., Fall P.A., Rockette H.E., Kurs-Lasky M., Bluestone C.D., et al. The heritability of otitis media: a twin and triplet study. JAMA 1999, 282(22):2125-2130.
42. Uhari M., Mantysaari K., Niemela M. A meta-analytic review of the risk factors for acute otitis media. Clin Infect Dis 1996, 22(6):1079-1083.
43. Frenck R.W., Glezen W.P. Respiratory tract infections in children in day care. Semin Pediatr Infect Dis 1990, 1:234-244.
44. Niemela M., Uhari M., Jounio-Ervasti K., Luotonen J., Alho O.P., Vierimaa E. Lack of specific symptomatology in children with acute otitis media. Pediatr Infect Dis J 1994, 13(9):765-768.
45. Kontiokari T., Koivunen P., Niemela M., Pokka T., Uhari M. Symptoms of acute otitis media. Pediatr Infect Dis J 1998, 17(8):676-679.
46. Appelman C.L., van Balen F.A., van de Lisdonk E.H., van Weert H.C., Eizenga W.H. NHG Practice Guideline: acute otitis media. Huisarts Wet 1990, 33:242-245.
47. Bain J., Townsley P., Boyle K., Dempster J., El-Ghorr A., Ewing P., et al. Diagnosis and management of childhood otitis media in primary care: a national clinical guideline 2003, Scottish Intercollegiate Guidelines Network, Edinburgh.
48. American Academy of Pediatrics Subcommittee on Management of Acute Otitis Media. Diagnosis and management of acute otitis media. Pediatrics 2004;113(5):1451-65.
49. Forgie S., Zhanel G., Robinson J. Management of acute otitis media. Paediatr Child Health 2009, 14(7):457-464.
50. Marchisio P., Bellussi L., Di Mauro G., Doria M., Felisati G., Longhi R., et al. Acute otitis media: from diagnosis to prevention. Summary of the Italian guideline. Int J Pediatr Otorhinolaryngol 2010, 74(11):1209-1216.
51. Wald E.R. Acute otitis media: more trouble with the evidence. Pediatr Infect Dis J 2003, 22:103-104.
52. Sanders S., Glasziou P.P., Del Mar C., Rovers M.M. Antibiotics for acute otitis media in children. Cochrane Database Syst Rev 2010, 1. CD000219-CD000219.
53. Hoberman A., Paradise J.L., Rockette H.E., et al. Treatment of acute otitis media in children under 2 years of age. N Engl J Med 2011, 364:105-115.
54. Tähtinen P.A., Laine M.K., Huovinen P., Jalava J., Ruuskanen O., Ruohola A. A placebo-controlled trial of antimicrobial treatment for acute otitis media. N Engl J Med 2011, 364:116-126.
55. American Academy of Pediatrics. Clinical practice guideline: management of sinusitis. Pediatrics 2001;108(3):798-808.
56. Juven T., Mertsola J., Toikka P., Virkki R., Leinonen M., Ruuskanen O. Clinical profile of serologically diagnosed pneumococcal pneumonia. Pediatr Infect Dis J 2001, 20(11):1028-1033.
57. Andrade ALSS, Oliveira R, Vieira MA, Minamisava R, Pessoa Jr V, Brandileone MCC, et al. Population-based surveillance for invasive pneumococcal disease and pneumonia in infants and young children in Goiânia, Brazil; 2011 [Submitted for publication].
58. Chetty K., Thomson A.H. Management of community-acquired pneumonia in children. Paediatr Drugs 2007, 9(6):401-411.
59. Handbook IMCI integrated management of childhood illness 2005, World Health Organization, UNICEF, Geneva, Switzerland. J. Thomson, A. Chavan (Eds.).
60. Cardoso M.R., Nascimento-Carvalho C.M., Ferrero F., Alves F.M., Cousens S.N. Adding fever to WHO criteria for diagnosing pneumonia enhances the ability to identify pneumonia cases among wheezing children. Arch Dis Child 2011, 96(1):58-61.
61. Ampofo K., Bender J., Sheng X., Korgenski K., Daly J., Pavia A.T., et al. Seasonal invasive pneumococcal disease in children: role of preceding respiratory viral infection. Pediatrics 2008, 122(2):229-237.
62. Madhi S.A., Klugman K.P. A role for Streptococcus pneumoniae in virus-associated pneumonia. Nat Med 2004, 10(8):811-813.
63. Madhi S.A., Ludewick H., Kuwanda L., Niekerk N., Cutland C., Little T., et al. Pneumococcal coinfection with human metapneumovirus. J Infect Dis 2006, 193(9):1236-1243.
64. O'Brien K.L., Walters M.I., Sellman J., Quinlisk P., Regnery H., Schwartz B., et al. Severe pneumococcal pneumonia in previously healthy children: the role of preceding influenza infection. Clin Infect Dis 2000, 30(5):784-789.
65. Chien Y.W., Klugman K.P., Morens D.M. Bacterial pathogens and death during the 1918 influenza pandemic. N Engl J Med 2009, 361(26):2582-2583.
66. Vu H.T., Yoshida L.M., Suzuki M., Nguyen H.A., Nguyen C.D., Nguyen A.T., et al. Association between nasopharyngeal load of Streptococcus pneumoniae, viral coinfection, and radiologically confirmed pneumonia in Vietnamese children. Pediatr Infect Dis J 2011, 30(1):11-18.
67. Tuomanen E.I., Austrian R., Masure H.R. Pathogenesis of pneumococcal infection. N Engl J Med 1995, 332(19):1280-1284.
68. Brundage J.F. Interactions between influenza and bacterial respiratory pathogens: implications for pandemic preparedness. Lancet Infect Dis 2006, 6(5):303-312.
69. de Andrade A.L., de Andrade J.G., Martelli C.M., e Silva S.A., de Oliveira R.M., Costa M.S., et al. Effectiveness of Haemophilus influenzae b conjugate vaccine on childhood pneumonia: a case-control study in Brazil. Int J Epidemiol 2004, 33(1):173-181.
70. Tan T.Q., Mason E.O., Wald E.R., Barson W.J., Schutze G.E., Bradley J.S., et al. Clinical characteristics of children with complicated pneumonia caused by Streptococcus pneumoniae. Pediatrics 2002, 110(1 Pt 1):1-6.
71. Wexler I.D., Knoll S., Picard E., Villa Y., Shoseyov D., Engelhard D., et al. Clinical characteristics and outcome of complicated pneumococcal pneumonia in a pediatric population. Pediatr Pulmonol 2006, 41(8):726-734.
72. Resti M., Moriondo M., Cortimiglia M., Indolfi G., Canessa C., Becciolini L., et al. Community-acquired bacteremic pneumococcal pneumonia in children: diagnosis and serotyping by real-time polymerase chain reaction using blood samples. Clin Infect Dis 2010, 51(9):1042-1049.
73. Shah S.S., Hall M., Newland J.G., Brogan T.V., Farris R.W., Williams D.J., et al. Comparative effectiveness of pleural drainage procedures for the treatment of complicated pneumonia in childhood. J Hosp Med 2011, 6(5):256-263.
74. Byington C.L., Spencer L.Y., Johnson T.A., Pavia A.T., Allen D., Mason E.O., et al. An epidemiological investigation of a sustained high rate of pediatric parapneumonic empyema: risk factors and microbiological associations. Clin Infect Dis 2002, 34(4):434-440.
75. Soares P., Barreira J., Pissarra S., Nunes T., Azevedo I., Vaz L. Pediatric parapneumonic pleural effusions: experience in a university central hospital. Rev Port Pneumol 2009, 15(2):241-259.
76. Hasley P.B., Albaum M.N., Li Y.H., Fuhrman C.R., Britton C.A., Marrie T.J., et al. Do pulmonary radiographic findings at presentation predict mortality in patients with community-acquired pneumonia?. Arch Intern Med 1996, 156(19):2206-2212.
77. Hernandez-Bou S., Garcia-Garcia J.J., Esteva C., Gene A., Luaces C., Munoz Almagro C. Pediatric parapneumonic pleural effusion: epidemiology, clinical characteristics, and microbiological diagnosis. Pediatr Pulmonol 2009, 44(12):1192-1200.
78. Hortal M., Sehabiague G., Camou T., Iraola I., Estevan M., Pujadas M. Pneumococcal pneumonia in hospitalized Uruguayan children and potential prevention with different vaccine formulations. J Pediatr 2008, 152(6):850-853.
79. Rees J.H., Spencer D.A., Parikh D., Weller P. Increase in incidence of childhood empyema in West Midlands, UK. Lancet 1997, 349(9049):402.
80. Singleton R.J., Hennessy T.W., Bulkow L.R., Hammitt L.L., Zulz T., Hurlburt D.A., et al. Invasive pneumococcal disease caused by nonvaccine serotypes among alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage. JAMA 2007, 297(16):1784-1792.
81. Hendrickson D.J., Blumberg D.A., Joad J.P., Jhawar S., McDonald R.J. Five-fold increase in pediatric parapneumonic empyema since introduction of pneumococcal conjugate vaccine. Pediatr Infect Dis J 2008, 27(11):1030-1032.
82. Spencer D.A., Iqbal S.M., Hasan A., Hamilton L. Empyema thoracis is still increasing in UK children. BMJ 2006, 332(7553):1333.
83. Nuorti JP, Griffin MR, Grijalva CG. The emergence of empyema in the United States. In: 7th International Symposium on Pneumocci, Pneumococcal, Diseases; 2010.
84. Obando I., Munoz-Almagro C., Arroyo L.A., Tarrago D., Sanchez-Tatay D., Moreno-Perez D., et al. Pediatric parapneumonic empyema, Spain. Emerg Infect Dis 2008, 14(9):1390-1397.
85. Pelton S.I., Huot H., Finkelstein J.A., Bishop C.J., Hsu K.K., Kellenberg J., et al. Emergence of 19A as virulent and multidrug resistant Pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine. Pediatr Infect Dis J 2007, 26(6):468-472.
86. Thomas M, Sheppard C, Cliff D, Guiver M, George R, Spencer D. Pneumococcal serotypes causing empyema in UK children from the enhanced surveillance programme - 2006-2009. Tel Aviv, Israel. In: 7th International Symposium on Pneumocci and Pneumococcal Diseases; 2010.
87. Byington C.L., Korgenski K., Daly J., Ampofo K., Pavia A., Mason E.O. Impact of the pneumococcal conjugate vaccine on pneumococcal parapneumonic empyema. Pediatr Infect Dis J 2006, 25(3):250-254.
88. Picazo J., Ruiz-Contreras J., Casado-Flores J., Negreira S., Del Castillo F., Hernandez-Sampelayo T., et al. Laboratory-based, 2-year surveillance of pediatric parapneumonic pneumococcal empyema following heptavalent pneumococcal conjugate vaccine universal vaccination in Madrid. Pediatr Infect Dis J 2011, 30(6):471-474.
89. Lagos R., Munoz A., San Martin O., Maldonado A., Hormazabal J.C., Blackwelder W.C., et al. Age- and serotype-specific pediatric invasive pneumococcal disease: insights from systematic surveillance in Santiago, Chile, 1994-2007. J Infect Dis 2008, 198(12):1809-1817.
90. Ferrero F., Nascimento-Carvalho C.M., Cardoso M.R., Camargos P., March M.F., Berezin E., et al. Radiographic findings among children hospitalized with severe community-acquired pneumonia. Pediatr Pulmonol 2010, 45(10):1009-1013.
91. Bekri H., Cohen R., Varon E., Madhi F., Gire R., Guillot F., et al. Streptococcus pneumoniae serotypes involved in children with pleural empyemas in France. Arch Pediatr 2007, 14(3):239-243.
92. Yu J., Salamon D., Marcon M., Nahm M.H. Pneumococcal serotypes causing pneumonia with pleural effusion in pediatric patients. J Clin Microbiol 2011, 49(2):534-538.
93. Picazo J., Ruiz-Contreras J., Hernandez B., Sanz F., Gutierrez A., Cercenado E., et al. Clonal and clinical profile of Streptococcus pneumoniae serotype 19A causing pediatric invasive infections: a 2-year (2007-2009) laboratory-based surveillance in Madrid. Vaccine 2011, 29(9):1770-1776.
94. Karakachoff M., Battagliotti C., Maciel J., Gamba N. Validation of a method to predict the etiology of pneumonia in children. Arch Argent Pediatr 2008, 106(2):126-131.
95. Don M., Valent F., Korppi M., Canciani M. Differentiation of bacterial and viral community-acquired pneumonia in children. Pediatr Int 2009, 51(1):91-96.
96. Nair H., Nokes D.J., Gessner B.D., Dherani M., Madhi S.A., Singleton R.J., et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet 2010, 375(9725):1545-1555.
97. Tan T.Q., Mason E.O., Barson W.J., Wald E.R., Schutze G.E., Bradley J.S., et al. Clinical characteristics and outcome of children with pneumonia attributable to penicillin-susceptible and penicillin-nonsusceptible Streptococcus pneumoniae. Pediatrics 1998, 102(6):1369-1375.
98. Michelow I.C., Olsen K., Lozano J., Rollins N.K., Duffy L.B., Ziegler T., et al. Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children. Pediatrics 2004, 113(4):701-707.
99. Cherian T., Mulholland E.K., Carlin J.B., Ostensen H., Amin R., de Campo M., et al. Standardized interpretation of paediatric chest radiographs for the diagnosis of pneumonia in epidemiological studies. Bull World Health Org 2005, 83(5):353-359.
100. Cheung Y.B., Zaman S.M., Ruopuro M.L., Enwere G., Adegbola R.A., Greenwood B., et al. C-reactive protein and procalcitonin in the evaluation of the efficacy of a pneumococcal conjugate vaccine in Gambian children. Trop Med Int Health 2008, 13(5):603-611.
101. Marrie T.J. Community-acquired pneumonia. Clin Infect Dis 1994, 18(4):501-513. [quiz 14-5].
102. Mushe DM. Streptococcus pneumoniae. In: Mandell GL, Bennett JE, Dolin R, editors. Mandell, Douglas, and Bennett's principles and practice of infectious diseases. 7th ed. Philadelphia, PA: Churchill Livingstone; 2009. p. 2623-42.
103. Dowell S.F., Garman R.L., Liu G., Levine O.S., Yang Y.H. Evaluation of Binax NOW, an assay for the detection of pneumococcal antigen in urine samples, performed among pediatric patients. Clin Infect Dis 2001, 32(5):824-825.
104. Le Monnier A., Carbonnelle E., Zahar J.R., Le Bourgeois M., Abachin E., Quesne G., et al. Microbiological diagnosis of empyema in children: comparative evaluations by culture, polymerase chain reaction, and pneumococcal antigen detection in pleural fluids. Clin Infect Dis 2006, 42(8):1135-1140.
105. Casado Flores J., Nieto Moro M., Berron S., Jimenez R., Casal J. Usefulness of pneumococcal antigen detection in pleural effusion for the rapid diagnosis of infection by Streptococcus pneumoniae. Eur J Pediatr 2010, 169(5):581-584.
106. Kaplan S.L., Mason E.O., Barson W.J., Tan T.Q., Schutze G.E., Bradley J.S., et al. Outcome of invasive infections outside the central nervous system caused by Streptococcus pneumoniae isolates nonsusceptible to ceftriazone in children treated with beta-lactam antibiotics. Pediatr Infect Dis J 2001, 20(4):392-396.
107. Byington C.L., Samore M.H., Stoddard G.J., Barlow S., Daly J., Korgenski K., et al. Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the intermountain west: emergence of nonvaccine serogroups. Clin Infect Dis 2005, 41(1):21-29.
108. Byington C.L., Hulten K.G., Ampofo K., Sheng X., Pavia A.T., Blaschke A.J., et al. Molecular epidemiology of pediatric pneumococcal empyema from 2001 to 2007 in Utah. J Clin Microbiol 2010, 48(2):520-525.
109. Schutze G.E., Tucker N.C., Mason E.O. Impact of the conjugate pneumococcal vaccine in Arkansas. Pediatr Infect Dis J 2004, 23(12):1125-1129.
110. Chibuk T.K., Robinson J.L., Hartfield D.S. Pediatric complicated pneumonia and pneumococcal serotype replacement: trends in hospitalized children pre and post introduction of routine vaccination with pneumococcal conjugate vaccine (PCV7). Eur J Pediatr 2010, 169(9):1123-1128.
111. Grant G.B., Campbell H., Dowell S.F., Graham S.M., Klugman K.P., Mulholland K., et al. Recommendations for treatment of childhood non-severe pneumonia. Lancet Infect Dis 2009, 9:185-196.
112. Sutijono D, Hom J, Zehtabchi S. Efficacy of 3-day versus 5-day antibiotic therapy for clinically diagnosed nonsevere pneumonia in children from developing countries. Eur J Emerg Med 2011. doi:10.1097/MEJ.0b013e328344fd90.
113. Kabra S.K., Lodha R., Pandey R.M. Antibiotics for community-acquired pneumonia in children. Cochrane Database Syst Rev 2010, (3 (March 17)):cd004874.
114. Chumpa A., Bachur R.G., Harper M.B. Bacteremia-associated pneumococcal pneumonia and the benefit of initial parenteral antimicrobial therapy. Pediatr Infect Dis J 1999, 18:1081-1085.
115. Echániz-Aviles G., Velázquez-Meza M.E., Carnalla-Barajas M.N., Soto-Noguerón A., Solórzano-Santos F., Pérez Miravete A., et al. Antimicrobial susceptibilities and capsular types of invasive Streptococcus pneumoniae isolated in children in Mexico City. Microb Drug Resist 1997, 3:153-157.
116. Hortal M., Camou T., Palacio R., Dibarboure H., García A. Ten-year review of invasive pneumococcal diseases in children and adults from Uruguay: clinical spectrum, serotypes, and antimicrobial resistance. Int J Infect Dis 2000, 4:91-95.
117. Pírez M.C., Algorta G., Cedrés A., Sobrero H., Varela A., Giachetto G., et al. Impact of universal pneumococcal vaccination on hospitalizations for pneumonia and meningitis in children in Montevideo. Uruguay. Pediatr Infect Dis J 2011, 30(8):669-674.
118. Plouffe J.F., Breiman R.F., Facklam R.R. Bacteremia with Streptococcus pneumoniae. Implications for therapy and prevention. Franklin County Pneumonia Study Group. JAMA 1996, 275:194-198.
119. Clifford V., Tebruegge M., Vandeleur M., Curtis N. Question 3: can pneumonia caused by penicillin-resistant Streptococcus pneumoniae be treated with penicillin?. Arch Dis Child 2010, 95:73-77.
120. Pallares R., Liñares J., Vadillo M., Cabellos C., Manresa F., Viladrich P.F., et al. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N Engl J Med 1995, 333:474-480.
121. Myers C., Gervaix A. Streptococcus pneumoniae bacteraemia in children. Int J Antimicrob Agents 2007, 30(Suppl 1):S24-S28.
122. Robinson K.A., Baughman W., Rothrock G., Barrett N.L., Pass M., Lexau C., et al. Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998: opportunities for prevention in the conjugate vaccine era. JAMA 2001, 285(13):1729-1735.
123. Lee G.M., Harper M.B. Risk of bacteremia for febrile young children in the post-Haemophilus influenzae type b era. Arch Pediatr Adolesc Med 1998, 152(7):624-628.
124. Kuppermann N. Occult bacteremia in young febrile children. Pediatr Clin North Am 1999, 46(6):1073-1109.
125. Bass J.W., Steele R.W., Wittler R.R., Weisse M.E., Bell V., Heisser A.H., et al. Antimicrobial treatment of occult bacteremia: a multicenter cooperative study. Pediatr Infect Dis J 1993, 12(6):466-473.
126. Kuppermann N., Fleisher G.R., Jaffe D.M. Predictors of occult pneumococcal bacteremia in young febrile children. Ann Emerg Med 1998, 31(6):679-687.
127. Ishimine P. Fever without source in children 0 to 36 months of age. Pediatr Clin North Am 2006, 53(2):167-194.
128. Lagos R.M., Munoz A.E., Levine M.M. Prevalence of pneumococcal bacteremia among children <36 months of age presenting with moderate fever to pediatric emergency rooms of the Metropolitan Region (Santiago), Chile. Hum Vaccin 2006, 2(3):129-133.
129. Joffe M.D., Alpern E.R. Occult pneumococcal bacteremia: a review. Pediatr Emerg Care 2010, 26(6):448-454. [quiz 55-7].
130. Alpern E.R., Alessandrini E.A., Bell L.M., Shaw K.N., McGowan K.L. Occult bacteremia from a pediatric emergency department: current prevalence, time to detection, and outcome. Pediatrics 2000, 106(3):505-511.
131. Rothrock S.G., Harper M.B., Green S.M., Clark M.C., Bachur R., McIlmail D.P., et al. Do oral antibiotics prevent meningitis and serious bacterial infections in children with Streptococcus pneumoniae occult bacteremia? A meta-analysis. Pediatrics 1997, 99(3):438-444.
132. Baraff L.J., Oslund S., Prather M. Effect of antibiotic therapy and etiologic microorganism on the risk of bacterial meningitis in children with occult bacteremia. Pediatrics 1993, 92(1):140-143.
133. Lagos R., Munoz A., Valenzuela M.T., Heitmann I., Levine M.M. Population-based surveillance for hospitalized and ambulatory pediatric invasive pneumococcal disease in Santiago, Chile. Pediatr Infect Dis J 2002, 21(12):1115-1123.
134. Stoll M.L., Rubin L.G. Incidence of occult bacteremia among highly febrile young children in the era of the pneumococcal conjugate vaccine: a study from a Children's Hospital Emergency Department and Urgent Care Center. Arch Pediatr Adolesc Med 2004, 158(7):671-675.
135. Alpern E.R., Alessandrini E.A., McGowan K.L., Bell L.M., Shaw K.N. Serotype prevalence of occult pneumococcal bacteremia. Pediatrics 2001, 108(2):E23.
136. Benito-Fernandez J., Raso S.M., Pocheville-Gurutzeta I., SanchezEtxaniz J., Azcunaga-Santibanez B., Capape-Zache S. Pneumococcal bacteremia among infants with fever without known source before and after introduction of pneumococcal conjugate vaccine in the Basque Country of Spain. Pediatr Infect Dis J 2007, 26(8):667-671.
137. Black S., Shinefield H., Baxter R., Austrian R., Bracken L., Hansen J., et al. Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente. Pediatr Infect Dis J 2004, 23(6):485-489.
138. Pilishvili T., Lexau C., Farley M.M., Hadler J., Harrison L.H., Bennett N.M., et al. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis 2010, 201(1):32-41.
139. Koedel U., Scheld W.M., Pfister H.W. Pathogenesis and pathophysiology of pneumococcal meningitis. Lancet Infect Dis 2002, 2(12):721-736.
140. Brandt C.T., Holm D., Liptrot M., Ostergaard C., Lundgren J.D., Frimodt-Moller N., et al. Impact of bacteremia on the pathogenesis of experimental pneumococcal meningitis. J Infect Dis 2008, 197(2):235-244.
141. Bingen E., Levy C., de la Rocque F., Boucherat M., Varon E., Alonso J.M., et al. Bacterial meningitis in children: a French prospective study. Clin Infect Dis 2005, 41(7):1059-1063.
142. Bingen E., Levy C., Varon E., de La Rocque F., Boucherat M., d'Athis P., et al. Pneumococcal meningitis in the era of pneumococcal conjugate vaccine implementation. Eur J Clin Microbiol Infect Dis 2008, 27(3):191-199.
143. Hsu H.E., Shutt K.A., Moore M.R., Beall B.W., Bennett N.M., Craig A.S., et al. Effect of pneumococcal conjugate vaccine on pneumococcal meningitis. N Engl J Med 2009, 360(3):244-256.
144. Levy C., Varon E., Bingen E., Lecuyer A., Boucherat M., Cohen R. PneumococcaL meningitis in french children before and after the introduction of pneumococcal conjugate vaccine. Pediatr Infect Dis J 2011, 30(2):168-170.
145. Leimkugel J., Adams Forgor A., Gagneux S., Pfluger V., Flierl C., Awine E., et al. An outbreak of serotype 1 Streptococcus pneumoniae meningitis in northern Ghana with features that are characteristic of Neisseria meningitidis meningitis epidemics. J Infect Dis 2005, 192(2):192-199.
146. Gessner B.D., Mueller J.E., Yaro S. African meningitis belt pneumococcal disease epidemiology indicates a need for an effective serotype 1 containing vaccine, including for older children and adults. BMC Infect Dis 2010, 10:22.
147. Yaro S., Lourd M., Traore Y., Njanpop-Lafourcade B.M., Sawadogo A., Sangare L., et al. Epidemiological and molecular characteristics of a highly lethal pneumococcal meningitis epidemic in Burkina Faso. Clin Infect Dis 2006, 43(6):693-700.
148. Ko A.I., Reis J.N., Coppola S.J., Gouveia E.L., Cordeiro S.M., Lobo T.S., et al. Clonally related penicillin-nonsusceptible Streptococcus pneumoniae serotype 14 from cases of meningitis in Salvador, Brazil. Clin Infect Dis 2000, 30(1):78-86.
149. Reis J.N., Cordeiro S.M., Coppola S.J., Salgado K., Carvalho M.G., Teixeira L.M., et al. Population-based survey of antimicrobial susceptibility and serotype distribution of Streptococcus pneumoniae from meningitis patients in Salvador, Brazil. J Clin Microbiol 2002, 40(1):275-277.
150. Asturias E.J., Soto M., Menendez R., Ramirez P.L., Recinos F., Gordillo R., et al. Meningitis and pneumonia in Guatemalan children: the importance of Haemophilus influenzae type b and Streptococcus pneumoniae. Rev Panam Salud Publica 2003, 14(6):377-384.
151. Simoes L.L., Andrade A.L., Laval C.A., Oliveira R.M., Silva S.A., Martelli C.M., et al. Impact of Haemophilus influenzae b (Hib) vaccination on meningitis in Central Brazil. Rev Saude Publica 2004, 38(5):664-670.
152. Edmond K., Clark A., Korczak V.S., Sanderson C., Griffiths U.K., Rudan I. Global and regional risk of disabling sequelae from bacterial meningitis: a systematic review and meta-analysis. Lancet Infect Dis 2010, 10(5):317-328.
153. da Gloria Carvalho M., Pimenta F.C., Jackson D., Roundtree A., Ahmad Y., Millar E.V., et al. Revisiting pneumococcal carriage by use of broth enrichment and PCR techniques for enhanced detection of carriage and serotypes. J Clin Microbiol 2010, 48(5):1611-1618.
154. Saha S.K., Darmstadt G.L., Baqui A.H., Hossain B., Islam M., Foster D., et al. Identification of serotype in culture negative pneumococcal meningitis using sequential multiplex PCR: implication for surveillance and vaccine design. PLoS One 2008, 3(10):e3576.
155. Lamaro-Cardoso J, Lemos AP, Carvalho Mda G, Pimenta FC, Roundtree A, Beall B, et al. 7th International Symposium on Pneumococci and Pneumococcal Diseases, Tel-Aviv, Israel. In: Multiplex PCR serotype deduction from pneumococcal carriage in day-care centers following a fatal case of serotype 22F meningitis; 2010.
156. Ulloa-Gutierrez R., Avila-Aguero M.L., Herrera M.L., Herrera J.F., Arguedas A. Invasive pneumococcal disease in Costa Rican children: a seven year survey. Pediatr Infect Dis J 2003, 22:1069-1074.
157. Gomez-Barreto D., Espinosa-Monteros L.E., Lopez-Enriquez C., Jimenez-Rojas V., Rodriguez-Suarez R. Invasive pneumococcal disease in a third level pediatric hospital in Mexico City: epidemiology and mortality risk factors. Salud Publica Mex 2010, 52(5):391-397.
158. Ariceta G., Besbas N., Johnson S., Karpman D., Landau D., Licht C., et al. Guideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome. Pediatr Nephrol 2009, 24(4):687-696.
159. Klein P.J., Bulla M., Newman R.A., Muller P., Uhlenbruck G., Schaefer H.E., et al. Thomsen-Friedenreich antigen in haemolytic-uraemic syndrome. Lancet 1977, 2(8046):1024-1025.
160. Geary D.F. Hemolytic uremic syndrome and streptococcus pneumoniae: improving our understanding. J Pediatr 2007, 151(2):113-114.
161. von Vigier R.O., Fossali E., Crosazzo L., Bianchetti M.G. Positive Coombs test in postpneumococcal hemolytic-uremic syndrome. Pediatr Infect Dis J 2005, 24(11):1028-1029.
162. von Vigier R.O., Seibel K., Bianchetti M.G. Positive Coombs test in pneumococcus-associated hemolytic uremic syndrome. A review of the literature. Nephron 1999, 82(2):183-184.
163. Somers M.J., Sharma A., Grant P.E., Guimaraes A.R., Schneeberger E.E. Case records of the Massachusetts General Hospital. Case 23-2009. A 13-year-old boy with headache, nausea, seizures, and hypertension. N Engl J Med 2009, 361(4):389-400.
164. Lee C.F., Liu S.C., Lue K.H., Chen J.P., Sheu J.N. Pneumococcal pneumonia with empyema and hemolytic uremic syndrome in children: report of three cases. J Microbiol Immunol Infect 2006, 39(4):348-352.
165. Waters A.M., Kerecuk L., Luk D., Haq M.R., Fitzpatrick M.M., Gilbert R.D., et al. Hemolytic uremic syndrome associated with invasive pneumococcal disease: the United kingdom experience. J Pediatr 2007, 151(2):140-144.
166. Martinot A., Hue V., Leclerc F., Chenaud M. Haemolytic-uraemic syndrome associated with Streptococcus pneumoniae meningitis. Eur J Pediatr 1989, 148(7):648-649.
167. Novak R.W., Martin C.R., Orsini E.N. Hemolytic-uremic syndrome and T-cryptantigen exposure by neuraminidase-producing pneumococci: an emerging problem?. Pediatr Pathol 1983, 1(4):409-413.
168. Cabrera G.R., Fortenberry J.D., Warshaw B.L., Chambliss C.R., Butler J.C., Cooperstone B.G. Hemolytic uremic syndrome associated with invasive Streptococcus pneumoniae infection. Pediatrics 1998, 101(4 Pt 1):699-703.
169. Nathanson S., Deschenes G. Prognosis of Streptococcus pneumoniae-induced hemolytic uremic syndrome. Pediatr Nephrol 2001, 16(4):362-365.
170. Brandt J., Wong C., Mihm S., Roberts J., Smith J., Brewer E., et al. Invasive pneumococcal disease and hemolytic uremic syndrome. Pediatrics 2002, 110(2 Pt 1):371-376.
171. Bender J.M., Ampofo K., Byington C.L., Grinsell M., Korgenski K., Daly J.A., et al. Epidemiology of Streptococcus pneumoniae-induced hemolytic uremic syndrome in Utah children. Pediatr Infect Dis J 2010, 29(8):712-716.
172. Bender J.M., Ampofo K., Korgenski K., Daly J., Pavia A.T., Mason E.O., et al. Pneumococcal necrotizing pneumonia in Utah: does serotype matter?. Clin Infect Dis 2008, 46(9):1346-1352.
173. Copelovitch L., Kaplan B.S. Streptococcus pneumoniae--associated hemolytic uremic syndrome: classification and the emergence of serotype 19A. Pediatrics 2010, 125(1):e174-e182.
174. Chautemps N., Milesi C., Cambonie G., Duquesne F., Adra-Delenne A.L., Ferragu F., et al. Pneumococcal hemolytic uremic syndrome: about 2 cases. Arch Pediatr 2008, 15(7):1206-1210.
175. Merieau E., Lanotte P., Chantreuil J., Cantagrel S. Streptococcus pneumoniae 19A-induced hemolytic-uremic syndrome: a new pathology?. Arch Pediatr 2008, 15(12):1825-1827.
176. Choi E.H., Kim S.H., Eun B.W., Kim S.J., Kim N.H., Lee J., et al. Streptococcus pneumoniae serotype 19A in children, South Korea. Emerg Infect Dis 2008, 14(2):275-281.
177. Annand W.F., Bowen W.H. Pneumococcal peritonitis. Lancet 1906, 1:1591-1597.
178. McCartney J.E., Fraser J. Pneumococcal peritonitis. Br J Surg 1922, 9:479-488.
179. Fowler R. Primary peritonitis: changing aspects 1956-1970. Aust Paediatr J 1971, 7(2):73-83.
180. Cole W.H. Pneumococcal peritonitis. Surgery 1937, 1:386-394.
181. Correia J.P., Conn H.O. Spontaneous bacterial peritonitis in cirrhosis: endemic or epidemic?. Med Clin North Am 1975, 59(4):963-981.
182. Denis F., Mounier M., Descottes B., Cubertafond P., Catanzano G. Abdominal infections caused by Streptococcus pneumoniae. Eur J Clin Microbiol 1984, 3(5):443.
183. Sen S., Lalitha M.K., Fenn A.S., Mammen K.E. Primary peritonitis in children. Ann Trop Paediatr 1983, 3(2):53-56.
184. Dugi D.D., Musher D.M., Clarridge J.E., Kimbrough R. Intraabdominal infection due to Streptococcus pneumoniae. Medicine (Baltimore) 2001, 80(4):236-244.
185. Iglesias Sanchez L., Perez-Yarza E.G., Garcia-Arenzana J.M., Valiente Mendez A., Perez-Trallero E. Epidemiology of invasive pneumococcal disease in children in Gipuzkoa (Spain) from 1981 to 2001. An Esp Pediatr 2002, 57(5):401-407.